Gara Jalqabaatti › Lupus › Texas › Houston
Qorannoo klinikaalii Lupus Houston, TX keessatti
Qorannoo 13 Lupus f Houston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
- UT MD Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 3
- Sl0044 50696, Houston
- Sl0044 50723, Houston
- Sl0044 50738, Bellaire · Miili 7 fagaatti
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Namoota walitti qabaa jiraSadarkaa 2
- The University of Texas Health Science Center at Houston, Houston
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Namoota walitti qabaa jiraSadarkaa 2
- Prolato Clinical Research Center, Houston
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Namoota walitti qabaa jiraSadarkaa 3
- Novel Research LLC, Bellaire · Miili 7 fagaatti
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Houston
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Houston
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Namoota walitti qabaa jiraSadarkaa 1
- Baylor College of Medicine, Houston
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Namoota walitti qabaa jiraSadarkaa 3
- Accurate Clinical Research, Humble · Miili 17 fagaatti
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Namoota walitti qabaa jiraSadarkaa 3
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · Miili 7 fagaatti
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Namoota walitti qabaa jiraQorannoo ilaalaa
- M D Anderson Cancer Center, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Qorannoo Lupus magaalota biroo keessatti
- New York City, NYQorannoo 18
- Durham, NCQorannoo 12
- Miami, FLQorannoo 11
- Washington, DCQorannoo 10
- Tampa, FLQorannoo 9
- Philadelphia, PAQorannoo 9
- Clearwater, FLQorannoo 8
- Santa Monica, CAQorannoo 8
- Oklahoma City, OKQorannoo 8
- Los Angeles, CAQorannoo 8
- Chicago, ILQorannoo 8
- Boston, MAQorannoo 8
Qorannoo biroo Houston keessatti
- Kansara Qara'a Non-Small CellQorannoo 145
- Saree OljooQorannoo 126
- Saree (Gosoota Hunda)Qorannoo 121
- Kansara MetastatikiiQorannoo 104
- Kansarii ColorectalQorannoo 102
- Kansarii OvariiQorannoo 89
- Leukemia Myeloidii HamaaQorannoo 85
- Dhibee QaraQorannoo 78
- Kansarii ProstateQorannoo 76
- Kansa EndometiriyaaliiQorannoo 68
- Kansarii PancreasQorannoo 61
- MelanomaQorannoo 59
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.